1. Home
  2. LVTX vs SURG Comparison

LVTX vs SURG Comparison

Compare LVTX & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LVTX
  • SURG
  • Stock Information
  • Founded
  • LVTX 2016
  • SURG 2006
  • Country
  • LVTX Netherlands
  • SURG United States
  • Employees
  • LVTX N/A
  • SURG N/A
  • Industry
  • LVTX Biotechnology: Pharmaceutical Preparations
  • SURG Advertising
  • Sector
  • LVTX Health Care
  • SURG Consumer Discretionary
  • Exchange
  • LVTX Nasdaq
  • SURG Nasdaq
  • Market Cap
  • LVTX 30.0M
  • SURG 27.0M
  • IPO Year
  • LVTX 2021
  • SURG N/A
  • Fundamental
  • Price
  • LVTX $1.25
  • SURG $2.80
  • Analyst Decision
  • LVTX Hold
  • SURG Strong Buy
  • Analyst Count
  • LVTX 3
  • SURG 1
  • Target Price
  • LVTX $3.17
  • SURG $8.75
  • AVG Volume (30 Days)
  • LVTX 48.1K
  • SURG 283.6K
  • Earning Date
  • LVTX 05-20-2025
  • SURG 05-20-2025
  • Dividend Yield
  • LVTX N/A
  • SURG N/A
  • EPS Growth
  • LVTX N/A
  • SURG N/A
  • EPS
  • LVTX N/A
  • SURG N/A
  • Revenue
  • LVTX $11,982,000.00
  • SURG $60,881,173.00
  • Revenue This Year
  • LVTX N/A
  • SURG $59.57
  • Revenue Next Year
  • LVTX N/A
  • SURG $75.47
  • P/E Ratio
  • LVTX N/A
  • SURG N/A
  • Revenue Growth
  • LVTX 77.01
  • SURG N/A
  • 52 Week Low
  • LVTX $0.85
  • SURG $1.05
  • 52 Week High
  • LVTX $3.20
  • SURG $4.38
  • Technical
  • Relative Strength Index (RSI)
  • LVTX 49.77
  • SURG 57.49
  • Support Level
  • LVTX $1.17
  • SURG $2.56
  • Resistance Level
  • LVTX $1.37
  • SURG $3.47
  • Average True Range (ATR)
  • LVTX 0.08
  • SURG 0.27
  • MACD
  • LVTX -0.01
  • SURG -0.06
  • Stochastic Oscillator
  • LVTX 29.85
  • SURG 33.00

About LVTX LAVA Therapeutics N.V.

LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: